MOSCOW (MRC) -- Asahi Kasei Medical Co., Ltd., a medical device company, has formed a 50:50 joint venture (JV) with Kuraray Medical Inc., a provider of dental bonding agents, dental cements, composite resins, and related material, for the production of hollow-fiber membrane for use in medical devices, using Eval ethylene-vinyl alcohol copolymer (EVOH) from Kuraray Co., Ltd., said 4-traders.
The JV company is named as A-K Membrane Manufacturing Co., Ltd.
Asahi Kasei Corp. integrated its two core operating companies in the medical devices-related field, Asahi Kasei Kuraray Medical Co., Ltd. and Asahi Kasei Medical Co., Ltd., as of April 1, 2012. As previously announced in our release dated August 3, 2011, Kuraray Co., Ltd. transferred the entirety of its 7% holding in Asahi Kasei Kuraray Medical to Asahi Kasei Corp. on April 1, 2012. Asahi Kasei Kuraray Medical became a wholly owned subsidiary of Asahi Kasei Corp. on that date.
As MRC informed earlier, Asahi Kasei Chemicals has opened a new production line for Duranol polycarbonatediol (PCD), and a second line for Duranate hexamethylene diisocyanate (HDI)-based polyisocyanate at its facility in Nantong, China. The company started commercial operation of the new Duranol line, and the second Duranate line, in November 2014 and May 2015 respectively.
Asahi Kasei Kuraray Medical Co.,Ltd. engages in the research and development, production, and sale of medical equipment in the fields of hemodialysis, therapeutic apheresis, transfusion therapy, and virus removal for biotherapeutic products in Japan and internationally. The company offers devices for the treatment of immunologic or intractable diseases, leukocyte reduction filters to prevent adverse effects associated with blood transfusion, and virus removal filters used in biopharmaceutical production.
MRC